BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37981023)

  • 21. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
    Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
    BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps.
    Low CM; Wang AR; Yong M; Nayak J; Patel Z; Hwang PH
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1249-1252. PubMed ID: 38297486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps.
    Parasher AK; Gliksman M; Segarra D; Lin T; Rudmik L; Quast T
    Int Forum Allergy Rhinol; 2022 Jun; 12(6):813-820. PubMed ID: 34874120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
    Koya T; Sakai N; Sasaki T; Shinbori K; Nagai A; Kimura Y; Toyama M; Hayashi M; Saito A; Nishiyama Y; Hasegawa T; Muramatsu Y; Muramatsu K; Horii A; Kikuchi T
    Int Arch Allergy Immunol; 2022; 183(3):289-297. PubMed ID: 34657036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupilumab-related adverse events among patients with chronic rhinosinusitis with nasal polyposis.
    Lee DJ; Cramer HB; Kshirsagar RS; Douglas JE; Kohanski MA; Palmer JN; Adappa ND; Bosso JV
    Int Forum Allergy Rhinol; 2023 Aug; 13(8):1542-1545. PubMed ID: 36394542
    [No Abstract]   [Full Text] [Related]  

  • 27. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies.
    Bachert C; Peters AT; Heffler E; Han JK; Olze H; Pfaar O; Chuang CC; Rout R; Attre R; Goga L; Jacob-Nara JA; Rowe PJ; Deniz Y; Chen Z; Kamat S; Siddiqui S
    Clin Exp Allergy; 2022 Feb; 52(2):244-249. PubMed ID: 35092110
    [No Abstract]   [Full Text] [Related]  

  • 29. Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
    Paoletti G; Casini M; Malvezzi L; Pirola F; Russo E; Nappi E; Muci GQ; Montagna C; Messina MR; Ferri S; Racca F; Lamacchia D; Cataldo G; Puggioni F; De Virgilio A; Ferreli F; Mercante G; Spriano G; Canonica GW; Heffler E
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):457-463. PubMed ID: 38095494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma.
    Bachert C; Hellings PW; Mullol J; Naclerio RM; Chao J; Amin N; Grabher A; Swanson BN; Hamilton JD; Guillonneau S; Taniou C; Zhang D; Pirozzi G; Graham NMH; Staudinger H; Mannent LP; Khan A
    J Allergy Clin Immunol Pract; 2019; 7(7):2447-2449.e2. PubMed ID: 30928658
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology?
    Nishiyama Y; Koya T; Nagano K; Abe S; Kimura Y; Shima K; Toyama-Kosaka M; Hasegawa T; Sasaki T; Shinbori K; Ueki S; Takamura K; Kikuchi T
    Allergol Int; 2022 Oct; 71(4):548-551. PubMed ID: 35443910
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps].
    Boiko NV; Stagnieva IV; Lodochkina OE; Kurbatova NV
    Vestn Otorinolaringol; 2023; 88(4):46-53. PubMed ID: 37767590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologics for chronic rhinosinusitis with nasal polyps.
    Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
    J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
    Kariyawasam HH
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.
    Orlando P; Licci G; Kuitche D; Matucci A; Vultaggio A; Gallo O; Maggiore G
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1317-1324. PubMed ID: 37910208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
    Mullol J; Bachert C; Amin N; Desrosiers M; Hellings PW; Han JK; Jankowski R; Vodicka J; Gevaert P; Daizadeh N; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1086-1095.e5. PubMed ID: 34628065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
    Schneider JS
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):698-9. PubMed ID: 27258602
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.
    Bachert C; Zhang L; Gevaert P
    J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.